These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10634264)

  • 21. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 22. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 23. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 24. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 25. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.
    Pratt RD; Perdomo CA
    Ann N Y Acad Sci; 2002 Nov; 977():513-22. PubMed ID: 12480794
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and tolerability of low-dose donepezil in schizophrenia.
    Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA
    Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donepezil-related toxic hepatitis.
    Dierckx RI; Vandewoude MF
    Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic advances: donepezil for the treatment of Alzheimer's disease.
    Misson J; Kendall MJ
    J Clin Pharm Ther; 1997 Aug; 22(4):251-5. PubMed ID: 9548205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An N-of-1 randomized controlled trial ('N-of-1 trial') of donepezil in the treatment of non-progressive amnestic syndrome.
    Price JD; Grimley Evans J
    Age Ageing; 2002 Jul; 31(4):307-9. PubMed ID: 12147570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
    Deleu D
    Neurology; 2002 Mar; 58(5):835-6; author reply 836. PubMed ID: 11889261
    [No Abstract]   [Full Text] [Related]  

  • 34. The emergence of pharmacotherapies for cognitive function in Down syndrome.
    Capone GT
    Am J Med Genet A; 2010 Dec; 152A(12):3026-7. PubMed ID: 21108389
    [No Abstract]   [Full Text] [Related]  

  • 35. Bipolar affective disorder, type II, apparently precipitated by donepezil.
    Collins C; Copeland B; Croucher M
    Int Psychogeriatr; 2011 Apr; 23(3):503-4. PubMed ID: 21092385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extra-pyramidal syndrome induced by donepezil].
    Carcenac D; Martin-Hunyadi C; Kiesmann M; Demuynck-Roegel C; Alt M; Kuntzmann F
    Presse Med; 2000 May; 29(18):992-3. PubMed ID: 10862247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.
    Handen BL; Johnson CR; McAuliffe-Bellin S; Murray PJ; Hardan AY
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):43-50. PubMed ID: 21309696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
    Ravina B; Putt M; Siderowf A; Farrar JT; Gillespie M; Crawley A; Fernandez HH; Trieschmann MM; Reichwein S; Simuni T
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):934-9. PubMed ID: 15965198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
    Wolff ML
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.